Jeffrey Friedman, M.D. Ph.D.

The Rockefeller University

Jeffrey M. Friedman, MD. Ph.D. Marilyn M. Simpson Professor, The Rockefeller University. Investigator, Howard Hughes Medical Institute. Dr. Friedman received an M.D. from Albany Medical College and a Ph.D. from Rockefeller in 1984. Dr. Friedman is known for his work on molecular mechanisms that regulate body weight. His group reported the isolation of the obese (ob) gene in mice and humans, and subsequently determined that the ob gene is responsible for producing leptin, a previously unknown hormone. Leptin plays a key role in controlling appetite, energy expenditure, and fat storage. Dr. Friedman’s current work centers on the molecular mechanisms of leptin action and the genetics of obesity and associated disorders. His research has been recognized by numerous awards, including the 2010 Albert Lasker Basic Medical Research Award, the BBVA Foundation Frontiers of Knowledge Award, the Shaw Prize for Life Sciences and Medicine, and the Gairdner Foundation International Award. He is a member of the National Academy of Science and the Institute of Medicine. Dr. Friedman was a scientific founder of Millennium Pharmaceuticals and Envoy Pharmaceuticals. He is also Chair of the Scientific Advisory Board at Bay City Capital.